-
REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN US PLATINUM-RESISTANT OVARIAN CANCER PATIENTS: CHARACTERIZING THE UNMET CLINICAL NEED
Feb 25, 2026, 14:43 PM -
IMPLEMENTATION OF EMBEDDED QUALITATIVE INTERVIEWS IN CLINICAL TRIALS: INSIGHTS FROM THE LITERATURE
Feb 25, 2026, 14:43 PM -
REAL-WORLD RELIABILITY AND VALIDITY OF THE EQ-5D-5L IN CHINESE PATIENTS WITH DIABETIC KIDNEY DISEASE: A CROSS-SECTIONAL STUDY
Feb 25, 2026, 14:43 PM -
THE IMPACT OF ESSENTIAL MEDICINES POLICIES ON HEALTH OUTCOMES: A SYSTEMATIC REVIEW
Feb 25, 2026, 14:43 PM -
COST-EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS VERSUS SGLT2 INHIBITORS FOR CARDIOVASCULAR PROTECTION AMONG U.S. ADULTS WITH DIABETES: A MEPS-BASED ECONOMIC EVALUATION 2022
Feb 25, 2026, 14:43 PM -
COST-EFFECTIVENESS OF AMIVANTAMAB PLUS LAZERTINIB FOR FIRST-LINE TREATMENT OF EGFR-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER: A U.S. PAYER PERSPECTIVE
Feb 25, 2026, 14:43 PM -
NURSE STAFFING RATIOS AND PATIENT OUTCOMES IN PENNSYLVANIA: POLICY IMPLICATIONS AND HOSPITAL COSTS
Feb 25, 2026, 14:43 PM -
TRENDS IN PREECLAMPSIA PREVALENCE AND COMORBIDITY BURDEN AMONG PREGNANT WOMEN USING U.S. ADMINISTRATIVE CLAIMS DATA
Feb 25, 2026, 14:43 PM -
US PAYER CURRENT AND FUTURE ADOPTION OF ARTIFICIAL INTELLIGENCE
Feb 25, 2026, 14:43 PM -
ESTIMATING STATE- AND COUNTY-LEVEL CHRONIC DISEASE AND RISK FACTOR PREVALENCE: VALIDATING A SYNTHETIC POPULATION APPROACH USING NATIONALLY REPRESENTATIVE SURVEY DATA
Feb 25, 2026, 14:43 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION & ASSOCIATED DRIVERS AMONG PATIENTS WITH OSTEOGENESIS IMPERFECTA
Feb 25, 2026, 14:43 PM -
EXAMINING THE EQUITY OF DISTRIBUTION OF GLP-1 PRESCRIPTIONS IN A LARGE URBAN PRIMARY CARE SYSTEM
Feb 25, 2026, 14:43 PM -
PREVALENCE RATES OF MYOTONIC DYSTROPHY TYPE 1 (DM1) IN 9 COUNTRIES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Feb 25, 2026, 14:43 PM -
COMPARATIVE ANALYSIS OF RISK FACTORS AND SHORT-TERM OUTCOMES AFTER PRIMARY PCI IN PRE- AND POST-MENOPAUSAL WOMEN WITH STEMI EXPERIENCE FROM LMIC
Feb 25, 2026, 14:43 PM -
A HOLISTIC EVALUATION OF ADVERSE EFFECTS ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY (ADT) IN PROSTATE CANCER: AN ARTIFICIAL INTELLIGENCE ASSISTED TARGETED LITERATURE REVIEW
Feb 25, 2026, 14:43 PM -
DISCORDANCE IN MARKET SHARE PARAMETERS IN BUDGET IMPACT ANALYSES: A REVIEW OF SUBMISSIONS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Feb 25, 2026, 14:43 PM -
COST ANALYSIS OF LUPUS NEPHRITIS IN THE BRAZILIAN UNIFIED HEALTH SYSTEM - RWD STUDY
Feb 25, 2026, 14:43 PM -
A METHODOLOGICAL REVIEW OF VALUATION STUDIES FOR THE EQ-5D-5L: EVOLVING PRACTICES AND LESSONS FROM THE EQ-5D-3L
Feb 25, 2026, 14:43 PM -
ECONOMIC BURDEN AND USE OF GLUCOSE-LOWERING MEDICATIONS IN U.S. ADULTS WITH DIABETES, BY CARDIOVASCULAR-KIDNEY-METABOLIC COMPONENTS: 2012-2021
Feb 25, 2026, 14:43 PM -
END-OF-LIFE AGGRESSIVE CARE AND ITS INFLUENCING FACTORS AMONG LUNG CANCER PATIENTS IN CHINA: A REAL-WORLD STUDY BASED ON DATA FROM CITY A
Feb 25, 2026, 14:43 PM
